Bio-Techne Corp at Stifel Healthcare Conference Transcript
Okay. Welcome, everybody. We're back on the Life Sciences and Diagnostics track at the Stifel Healthcare Conference. Happy to have Bio-Techne with us. Jim Hippel, CFO; Kim Kelderman, from Diagnostics and Genomics Group. Thanks, guys, very much for being with us today. A lot to talk about as is usually the case with these things. We're 1 quarter into fiscal '23, but I thought maybe a good idea would be to just sort of look back at fiscal '22 as a starting point. 17% organic growth that came off of a 22% COVID rebound year.
Questions & Answers
Maybe you can just talk a little bit about the business and what's driving growth right now as we hopefully continue to exit this pandemic period.
Yes, sure. I mean I'll
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
